Pharmacoperone identification for therapeutic rescue of misfolded mutant proteins
G protein-coupled receptors (GPCRs), which includes the gonadotropin releasing hormone (GnRH) receptor (GnRHR), comprises the largest family of validated drug targets—more than half of all approved drugs derive their benefits by selective targeting of GPCRs. Most drugs in this class are either agoni...
Main Authors: | P Michael eConn, Jo Ann eJanovick |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2011.00006/full |
Similar Items
-
Ipsen 5i is a novel potent pharmacoperone for intracellularly retained melanocortin-4 receptor mutants
by: Ya-Xiong eTao, et al.
Published: (2014-08-01) -
Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugs.
by: Jo Ann Janovick, et al.
Published: (2011-01-01) -
Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism
by: Jin-Beom Si, et al.
Published: (2021-04-01) -
The Role of Protein S-Nitrosylation in Protein Misfolding-Associated Diseases
by: Yun-Jin Ju, et al.
Published: (2021-07-01) -
Protein Folding and Misfolding on Surfaces
by: Massimo Stefani
Published: (2008-12-01)